# First trimester prediction of gestational diabetes mellitus by machine learning in twin pregnancies

**Authors:** Yoram Louzoun, Tamar Michelson, Mar Bennasar, Ran Svirsky, Elisa Bevilacqua, Nadav Kugler, Karl Kagan, Richard Nicholas Brown, Heidy Portillo Rodriguez, Anna Goncé, Antoni Borrell, Julia Ponce, Annegret Geipel, Adeline Walter, Corinna Simonini, Brigitte Strizek, Tanja Lennartz, Armin Bauer, Federica Meli, Eleonora Torcia, Adi Sharabi-Nov, Ron Maymon, Kypros H. Nicolaides, Hamutal Meiri

PMC · DOI: 10.1007/s00404-025-08262-6 · Archives of Gynecology and Obstetrics · 2026-01-20

## TL;DR

This study developed a machine learning model to predict gestational diabetes in twin pregnancies during the first trimester, finding that BMI and blood cell counts are strong predictors.

## Contribution

A novel machine learning model for early prediction of gestational diabetes in twin pregnancies using first-trimester data.

## Key findings

- LightGBM model achieved an AUC of 0.72 for predicting gestational diabetes in twin pregnancies.
- First-trimester BMI was the strongest predictor of gestational diabetes.
- An app for predicting GDM risk is available at twin-pe.math.biu.ac.il.

## Abstract

We aimed to develop a machine learning model for first-trimester prediction of gestational diabetes mellitus (GDM) in twin pregnancies using a prospective international, multi-center cohort and identify useful predictive markers.

Pregnant women with two live fetuses were enrolled at 11 + 0 to 13 + 6 weeks’ gestation and followed until delivery. GDM was diagnosed at 24–28 weeks’ gestation using the two-stage GCT and OGTT tests. Biochemical, biophysical, and blood assessments were conducted at three periods during pregnancy. Multiple machine learning models evaluated demographic, clinical, and laboratory parameters, including maternal factors (BMI, age, medical history), sonographic markers (crown rump length, estimated fetal weight, uterine artery pulsatility index), and blood and biochemical markers (placental growth factors, blood glucose, cell counts). LightGBM, XGBoost, and logistic regression models were compared using area under the curve (AUC) analysis.

Among 596 women, 99 (16.6%) developed GDM. LightGBM demonstrated superior performance (AUC = 0.72, 95% CI 0.69–0.75). First-trimester high BMI was the strongest predictor, followed by elevated white blood cell counts and platelet levels. Detection rates (DR) were 28% and 42% at 10% and 20% false positive rates (FPR), respectively. Previous GDM was associated with an increased risk for GDM.

GDM in twins is associated with certain characteristics of the first-trimester. Information from later trimesters has a limited impact. The GDM probability risk score increased with the severity of the treatment. An app to predict this score is available at: twin-pe.math.biu.ac.il.

The online version contains supplementary material available at 10.1007/s00404-025-08262-6.

## Linked entities

- **Diseases:** gestational diabetes mellitus (MONDO:0005406)

## Full-text entities

- **Diseases:** GDM (MESH:D016640)
- **Chemicals:** glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12819435/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12819435/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12819435/full.md

---
Source: https://tomesphere.com/paper/PMC12819435